个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhou, Jian[1] * ; Sun, Huichuan[1] ; Wang, Zheng[1] ; Cong, Wenming[2] ; Wang, Jianhua[3] ; Zeng, Mengsu[4] ; Zhou, Weiping[5] ; Bie, Ping[6] ; Liu, Lianxin[7] ; Wen, Tianfu[8] ; Han, Guohong[9] ; Wang, Maoqiang[10] ; Liu, Ruibao[11] ; Lu, Ligong[12] ; Ren, Zhengang[1] ; Chen, Minshan[13] ; Zeng, Zhaochong[14] ; Liang, Ping[15] ; Liang, Changhong[16] ; Chen, Min[17] ; Yan, Fuhua[18] ; Wang, Wenping[19] ; Ji, Yuan[20] ; Yun, Jingping[21] ; Cai, Dingfang[22] ; Chen, Yongjun[23] ; Cheng, Wenwu[24] ; Cheng, Shuqun[5] ; Dai, Chaoliu[25] ; Guo, Wenzhi[26] ; Hua, Baojin[27] ; Huang, Xiaowu[1] ; Jia, Weidong[28] ; Li, Yaming[29] ; Li, Yexiong[30] ; Liang, Jun[31] ; Liu, Tianshu[32] ; Lv, Guoyue[33] ; Mao, Yilei[34] ; Peng, Tao[35] ; Ren, Weixin[36] ; Shi, Hongcheng[37] ; Shi, Guoming[1] ; Tao, Kaishan[38] ; Wang, Wentao[8] ; Wang, Xiaoying[1] ; Wang, Zhiming[39] ; Xiang, Bangde[40] ; Xing, Baocai[41] ; Xu, Jianming[42] ; Yang, Jiamei[5] ; Yang, Jianyong[43] ; Yang, Yefa[44] ; Yang, Yunke[47] ; Ye, Shenglong[1] ; Yin, Zhengyu[45] ; Zhang, Bixiang[46] ; Zhang, Boheng[1] ; Zhang, Leida[22] ; Zhang, Shuijun[26] ; Zhang, Ti[48] ; Zhao, Yongfu[26] ; Zheng, Honggang[49] ; Zhu, Jiye[50] ; Zhu, Kangshun[51] ; Liu, Rong[3] ; Shi, Yinghong[1] ; Xiao, Yongsheng[1] ; Dai, Zhi[1] ; Teng, Gaojun[52] ; Cai, Jianqiang[53] ; Wang, Weilin[54] ; Cai, Xiujun[55] ; Li, Qiang[56] ; Shen, Feng[5] ; Qin, Shukui[56] ; Dong, Jiahong[57] ; Fan, Jia[1] ;
单位： [1]Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China [2]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Pathol, Shanghai, Peoples R China [3]Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai, Peoples R China [4]Fudan Univ, Zhongshan Hosp, Dept Radiol, Shanghai, Peoples R China [5]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 3, Shanghai, Peoples R China [6]Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China [7]Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China [8]Sichuan Univ, Dept Liver Surg, West China Hosp, Chengdu, Peoples R China [9]Fourth Mil Med Univ, Xijing Hosp, Dept Liver Dis & Digest Intervent Radiol, Xian, Peoples R China [10]Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Radiol, Beijing, Peoples R China [11]Harbin Med Univ, Dept Intervent Radiol, Tumor Hosp, Harbin, Peoples R China [12]Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Intervent Oncol, Guangzhou, Peoples R China [13]Sun Yat Sen Univ, Dept Hepatobiliary Surg, Canc Ctr, Guangzhou, Peoples R China [14]Fudan Univ, Zhongshan Hosp, Dept Radiat Oncol, Shanghai, Peoples R China [15]Chinese Peoples Liberat Army Gen Hosp, Dept Intervent Ultrasound, Beijing, Peoples R China [16]Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Peoples R China [17]Editorial Dept Chinese Journal Digest Surg, Chongqing, Peoples R China [18]Shanghai Jiao Tong Univ, Dept Radiol, Sch Med, Ruijin Hosp, Shanghai, Peoples R China [19]Shanghai Jiao Tong Univ, Sch Med, Dept Ultrasound, Zhongshan Hosp, Shanghai, Peoples R China [20]Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai, Peoples R China [21]Sun Yat Sen Univ, Tumor Prevent & Treatment Ctr, Dept Pathol, Guangzhou, Peoples R China [22]Fudan Univ, Zhongshan Hosp, Dept Integrat Med, Shanghai, Peoples R China [23]Shanghai Jiao Tong Univ, Ruijin Hosp North, Dept Hematol, Sch Med, Shanghai, Peoples R China [24]Fudan Univ, Dept Integrated Therapy, Shanghai Canc Ctr, Shanghai, Peoples R China [25]China Med Univ, Affiliated Shengjing Hosp, Dept Hepatobiliary & Spleenary Surg, Shenyang, Peoples R China [26]Zhengzhou Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China [27]Beijing Univ Chinese Med, Grad Sch, Beijing, Peoples R China [28]Anhui Med Univ, Affiliated Prov Hosp, Dept Hepat Surg, Hefei, Peoples R China [29]China Med Univ, Dept Nucl Med, Hosp 1, Shenyang, Peoples R China [30]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr Canc Hosp, Dept Radiat Oncol, Beijing, Peoples R China [31]Peking Univ Int Hosp, Dept Oncol, Beijing, Peoples R China [32]Fudan Univ, Zhongshan Hosp, Dept Oncol, Shanghai, Peoples R China [33]First Hosp Jilin Univ, Dept Gen Surg, Changchun, Jilin, Peoples R China [34]PUMC & Chinese Acad Med Sci, Peking Union Med Coll PUMC Hosp, Dept Liver Surg, Beijing, Peoples R China [35]Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Nanning, Peoples R China [36]Xinjiang Med Univ, Dept Intervent Radiol, Affiliated Hosp 1, Urumqi, Peoples R China [37]Fudan Univ, Zhongshan Hosp, Dept Nucl Med, Shanghai, Peoples R China [38]Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian, Peoples R China [39]Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Peoples R China [40]Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Tumor Hosp, Nanning, Peoples R China [41]Peking Univ Canc Hosp & Inst, Dept HepatoPancreatobiliary Surg, Beijing, Peoples R China [42]Acad Mil Med Sci, Affiliated Hosp Canc Ctr, Dept Gastrointestinal Oncol, Beijing, Peoples R China [43]Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China [44]Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg & Intervent Radiol, Shanghai, Peoples R China [45]Xiamen Univ, Dept Hepatobiliary Surg, Zhongshan Hosp, Hubing South Rd, Xiamen, Peoples R China [46]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China [47]Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Surg Inst, Chongqing, Peoples R China [48]Tianjin Med Univ Canc Inst & Hosp, Dept Hepatobiliary Surg, Tianjin, Peoples R China [49]Guang Anmen Hosp, China Acad Chinese Med Sci, Dept Oncol, Beijing, Peoples R China [50]Peking Univ Peoples Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China [51]Guangzhou Med Univ, Dept Minimally Invas Intervent Radiol, Affiliated Hosp 1, Guangzhou, Peoples R China [52]Southeast Univ, Zhongda Hosp, Med Sch, Dept Radiol, Nanjing, Peoples R China [53]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg Oncol, Beijing, Peoples R China [54]Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China [55]Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gen Surg, Hangzhou, Peoples R China [56]Nanjing Bayi Hosp, PLA Canc Ctr, Dept Med Oncol, Nanjing, Peoples R China [57]Tsinghua Univ, Beijing Tsinghua Changgung Hosp BTCH, Sch Clin Med, Dept Hepatobiliary & Pancreas Surg, Beijing, Peoples R China
出处：
DOI： 10.1159/000509424
ISSN：

关键词： Cancer Carcinoma China Liver Treatment Diagnosis

摘要：
Background: Primary liver cancer, around 90% are hepatocellular carcinoma in China, is the fourth most common malignancy and the second leading cause of tumor-related death, thereby posing a significant threat to the life and health of the Chinese people. Summary: Since the publication of Guidelines for Diagnosis and Treatment of Primary Liver Cancer (2017 Edition) in 2018, additional high-quality evidence has emerged with relevance to the diagnosis, staging, and treatment of liver cancer in and outside China that requires the guidelines to be updated. The new edition (2019 Edition) was written by more than 70 experts in the field of liver cancer in China. They reflect the real-world situation in China regarding diagnosing and treating liver cancer in recent years. Key Messages: Most importantly, the new guidelines were endorsed and promulgated by the Bureau of Medical Administration of the National Health Commission of the People's Republic of China in December 2019.

语种：
外文
高被引：
热点：
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2019]版：
大类 | 2 区 医学
小类 | 2 区 胃肠肝病学 2 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学 2 区 肿瘤学
JCR分区：
出版当年[2018]版：
Q1 ONCOLOGY Q1 GASTROENTEROLOGY & HEPATOLOGY
最新[2023]版：
Q1 GASTROENTEROLOGY & HEPATOLOGY Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者：
第一作者单位： [1]Fudan Univ, Zhongshan Hosp, Liver Canc Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhou Jian,Sun Huichuan,Wang Zheng,et al.Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)[J].LIVER CANCER.2020,9(6):682-720.doi:10.1159/000509424.
APA：
Zhou, Jian,Sun, Huichuan,Wang, Zheng,Cong, Wenming,Wang, Jianhua...&Fan, Jia.(2020).Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).LIVER CANCER,9,(6)
MLA：
Zhou, Jian,et al."Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)".LIVER CANCER 9..6(2020):682-720

相关文献

[1]Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) [2]Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021) [3]Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition) [4]Epstein-Barr virus negative primary hepatic leiomyoma: Case report and literature review [5]Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China [6]Epstein-Barr virus negative primary hepatic leiomyoma: Case report and literature review [7]Gold nanoparticles delivered miR-375 for treatment of hepatocellular carcinoma [8]Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis [9]Surgical treatment of hepato-pancreato-biliary disease in China: the Tongji experience [10]Diagnosis and treatment of Helicobacter pylori infection by physicians in China: A nationwide cross-sectional study

资源点击量：426 今日访问量：2 总访问量：410 更新日期：2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）